Ferrocene-based compounds with antimalaria/anticancer activity

114Citations
Citations of this article
168Readers
Mendeley users who have this article in their library.

Abstract

Malaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antimalarial and anticancer. Drugs such as ferroquine were developed from ferrocene and chloroquine. It was tested in the 1990s as an antimalarial and is still an effective antimalarial. Many researchers have reported ferrocene compounds as potent compounds useful as anticancer and antimalarial agents when hybridized with other pharmaceutical scaffolds. This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.

Cite

CITATION STYLE

APA

Peter, S., & Aderibigbe, B. A. (2019, October 7). Ferrocene-based compounds with antimalaria/anticancer activity. Molecules. MDPI AG. https://doi.org/10.3390/molecules24193604

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free